Ledger.Open graph →
SEC Form D · filed August 19, 2016

FATE THERAPEUTICS INC

Offering
$10.3M
Sold
$10.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Cindy D. Tahl · San Diego, CAExecTimothy P. Coughlin · San Diego, CADirectorJ. Scott Wolchko · San Diego, CAExec · DirectorWilliam S. Rastetter · San Diego, CADirectorAmir S. Nashat · San Diego, CADirectorJohn S. Mendlein · San Diego, CADirectorRobert S. Epstein · San Diego, CADirectorJesper P. Anderson · Freemont, CADirectorMatthew W. Collins · Canton, MADirectorHarley L. Stowell, Iii · Canton, MADirectorKimmie Serrano · Payette, IDDirectorPeter P. Siwinski · San Francisco, CADirectorDavid Burns · GARDENA, CAExec · DirectorMatthew Petros · GARDENA, CAExecDaniel D. Shoemaker · San Diego, CAExecStewart S. Abbot · San Diego, CAExecMark J. Enyedy · San Diego, CADirectorChris D. Storgard · San Diego, CAExecKen Hood · GARDENA, CADirectorMichael Feinstein · Chciago, ILDirectorPaul A. Froning · Chicago, ILDirectorScott R. Macgregor · Chicago, ILDirectorFocus Healthcare Partners LLC · Chicago, ILDirectorCurt P. Schaller · Chicago, ILExec · DirectorFocus SH I GP LLC · Chicago, ILExecDaniel D. Shoemaker · San Diego, CAExecStewart S. Abbot · San Diego, CAExecMark J. Enyedy · San Diego, CADirectorChris D. Storgard · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗